Type 2 diabetes trials in Latvia
3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Daugavpils, Jelgava, Ogre, Riga, Siguldas Pagasts, Ventspils
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - No phaseEnrolling by invitationPost-Market Clinical Follow-Up of the CT3 Series Continuous Glucose Monitoring System: A 14-Day Observational Study Assessing Accuracy, Safety, and Glucose Control in Patients With Type 1 and Type 2 Diabetes Mellitus
- Where
- Riga
- Age
- 18 years to 80 years
- People
- 72
- Run by
- MDCECRO LLC
See details and how to joinNCT07122180 - No phaseEnrolling by invitationEnhancing the Efficacy and Tolerability of Metformin by add-on Polyherbal Formulation: a Gut Microbiome Study
- Where
- Riga
- Age
- 25 years to 80 years
- People
- 66
- Run by
- Pauls Stradins Clinical University Hospital
See details and how to joinNCT06846138